Your browser doesn't support javascript.
loading
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Jørstad, Øystein Kalsnes; Foss, Stian; Gjølberg, Torleif Tollefsrud; Mester, Simone; Nyquist-Andersen, Mari; Sivertsen, Magne Sand; Fossum, Dag; Gleditsch, Espen; Moe, Morten Carstens; Andersen, Jan Terje.
Afiliación
  • Jørstad ØK; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. OEYJOE@ous-hf.no.
  • Foss S; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Gjølberg TT; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Mester S; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.
  • Nyquist-Andersen M; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Sivertsen MS; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Fossum D; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.
  • Gleditsch E; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Moe MC; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Andersen JT; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.
Int J Retina Vitreous ; 9(1): 65, 2023 Nov 07.
Article en En | MEDLINE | ID: mdl-37936232

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Retina Vitreous Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Retina Vitreous Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido